SCHEMBL3333528

SCHEMBL3333528

c1cc(C2NCCC23CCNC3)ccn1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.34
CYP2D6 P10635 3/20 0.33
HPGD P15428 1/20 0.33
ALDH1A1 P00352 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2C19 P33261 2/20 0.32
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
DDB1 Q16531 1/20 0.32
CRBN Q96SW2 1/20 0.32
HTR2A P28223 2/20 0.30
DRD2 P14416 1/20 0.30
SLC6A2 P23975 1/20 0.30
HTR2C P28335 1/20 0.30
SLC6A4 P31645 1/20 0.30
ADRB2 P07550 1/20 0.30
NCF1 P14598 1/20 0.30
PLD1 Q13393 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3333534 0.77 CYP2D6 (0.33) RECQLCYP2D6HPGDALDH1A1CYP3A4
SCHEMBL11888742 0.73 CYP2D6 (0.36) RECQLCYP2D6HPGDALDH1A1CYP3A4
SCHEMBL15571073 0.70 SIGMAR1 (0.42) CYP2D6CYP3A4CYP2C9TSHRHTR2A
SCHEMBL2303349 0.69 CYP2D6 (0.38) RECQLCYP2D6HPGDALDH1A1CYP3A4
SCHEMBL8226523 0.68 MAPT (0.39) TSHRHTR2C
SCHEMBL8224072 0.68 MAPT (0.39) CYP2D6ALDH1A1HTR2ASLC6A2HTR2C
SCHEMBL11888734 0.68 DDB1 (0.40) CYP2D6HPGDALDH1A1CYP3A4CYP2C19
SCHEMBL30405912 0.67 CYP2D6 (0.31) CYP2D6HPGDALDH1A1CYP3A4CYP2C19
SCHEMBL484676 0.67 CYP2D6 (0.40) CYP2D6HPGDALDH1A1CYP3A4CYP2C19
SCHEMBL29077956 0.61 CYP2D6 (0.37) RECQLCYP2D6HPGDALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152158-A1 Substituted Disulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-06-17 US claimed
CN-119775261-A Collagen 1 translation inhibitors and methods of use thereof 艾尼莫生物科技公司 2025-04-08 CN disclosed
CN-115427404-B Collagen 1 translation inhibitors and methods of use thereof 艾尼莫生物科技公司 2024-12-13 CN disclosed
CN-115427404-A Collagen 1 translation inhibitors and methods of use thereof 艾尼莫生物科技公司 2022-12-02 CN disclosed
US-20100152158-A1 Substituted Disulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152158-A1 Substituted Disulfonamide Compounds BDKRB1, BDKRB2, BRS3 RECQL 585/4885CYP2D6 1247/4885HPGD 2320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.